Jan Pot, Author at Kluwer Patent Blog

Netherlands, Pharma, Scope of protection

Bayer / Sandoz: a step forward for Dutch patent law

Jan Pot (Brinkhof)/June 10, 2016June 14, 2016

Claim construction and scope of protection are perhaps the most hotly contested topics in Dutch patent law. Over the last ten years, we have had no less than six Supreme Court decisions dealing with these matters. The latest development in this continuing saga is the Supreme Court’s recent decision in Bayer / Sandoz, which offers…

Case Law, Netherlands

The Netherlands: Resolution Chemicals v. Shionogi and AstraZeneca, District Court of The Hague, C/09/468395, 15 July 2015

Jan Pot (Brinkhof)/August 5, 2015

The District Court holds that Shionogi’s SPC for rosuvastatin (Crestor®) is invalid in part for added matter and grants a declaration of non-infringement for Resolution Chemicals’ proposed zinc salt of rosuvastatin. A full summary of this case has been published on Kluwer IP Law.